Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3
Min Huang(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Pu Han(Chinese Academy of Sciences), Yu Hu(University of Science and Technology of China), Anqi Zheng(Chinese Academy of Sciences), Qihui Wang(Shanxi Agricultural University), Sheng Niu(Shanxi Agricultural University), Zengyuan Zhang(Chinese Academy of Sciences), Pei Du(Chinese Academy of Sciences), Pengcheng Han(Zhongda Hospital Southeast University), Kefang Liu(Wenzhou Medical University), Ziliang Hu(Anhui University), Kaige Cui(Chinese Academy of Sciences), Yunfei Jia(Xi'an University of Science and Technology), Yufeng Xie(Chinese Academy of Sciences), Jianxun Qi(Chinese Academy of Sciences), Weiwei Li(Yancheng Institute of Technology), Xin Zhao(Chinese Academy of Sciences), Lili Wu(Chinese Academy of Sciences), Shixiong Hu(Shanxi Agricultural University), Qingwen He(Chinese Academy of Sciences), Linjie Li(Shanxi Provincial Cancer Hospital), Runchu Zhao(Chinese Academy of Sciences), Bin Bai(Chinese Academy of Sciences), Xiaoyu Rong(Wenzhou Medical University), Bo Liu(South China Agricultural University), Honghui Liu(Chinese Academy of Sciences)
Cited by 101
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k